NCT01387906View on ClinicalTrials.gov

Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo

PHASE4CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

June 30, 2012

Conditions

Hypotrichosis

Interventions

DRUG

topical bimatoprost

topical bimatoprost will be applied one drop to each eyebrow each night.

Trial Locations (1)

33401

Kenneth R. Beer, M.D. ,PA, West Palm Beach

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Allergan

INDUSTRY

lead

Kenneth Beer

INDIV